Gregory I. Frost
2011
In 2011, Gregory I. Frost earned a total compensation of $683.5K as Former President and Chief Executive Officer at Halozyme Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $80,000 |
|---|---|
| Option Awards | $7,316 |
| Salary | $415,000 |
| Stock Awards | $173,420 |
| Other | $7,788 |
| Total | $683,524 |
Frost received $415K in salary, accounting for 61% of the total pay in 2011.
Frost also received $80K in non-equity incentive plan, $7.3K in option awards, $173.4K in stock awards and $7.8K in other compensation.
Rankings
In 2011, Gregory I. Frost's compensation ranked 7,014th out of 10,747 executives tracked by ExecPay. In other words, Frost earned more than 34.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,014 out of 10,747 | 35th |
Division Manufacturing | 2,558 out of 3,960 | 35th |
Major group Chemicals And Allied Products | 615 out of 1,033 | 41st |
Industry group Drugs | 418 out of 781 | 47th |
Industry Biological Products, Except Diagnostic Substances | 68 out of 157 | 57th |
Source: SEC filing on April 7, 2014.
Frost's colleagues
We found six more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2011.
2011
James Shaffer
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2011
Jean Liu
Halozyme Therapeutics
General Counsel
2011
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2011
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2011
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2011
David Ramsay
Halozyme Therapeutics